Profile
AVGR ISRG BDX BDXA ALC MDLN
Company Name Avinger, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. Medline Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $1.52M $169.97B $59.94B $55.91B $39.26B $36.18B
Employees 0.07K 15.64K 70.00K 0.00K 25.60K 43.00K
CEO Nabeel P. Subainati CPA David J. Rosa Thomas E. Polen Jr. - David J. Endicott James Boyle
Ratings
AVGR ISRG BDX BDXA ALC MDLN
Quant Rating Score 2 3 3 5 3 3
Quant Rating Sell Neutral Neutral Strong Buy Neutral Neutral
Trading
AVGR ISRG BDX BDXA ALC MDLN
Last Close $0.474 $546.71 $190.98 $59.24 $76.61 -
High 52 $1.45 $610.45 $249.08 $59.24 $98.3 -
Low 52 $0.38 $429.59 $165.15 $59.24 $72.05 -
Price vs. 52 Week High -67.31 % -10.44 % -23.33 % 0 % -22.07 % -
Price vs. 52 Week Low 24.74 % 27.26 % 15.64 % 0 % 6.33 % -
Total Return
AVGR ISRG BDX BDXA ALC MDLN
1 Month Return 0 % 22.54 % 0.99 % 0 % 2 % -
3 Month Return 0 % 13.64 % -2.06 % 0 % -13.07 % -
6 Month Return 0 % -3 % 8.88 % 0 % -14.72 % -
9 Month Return 0 % -9.02 % -15.17 % 0 % -14.35 % -
YTD Return -42.05 % 4.74 % -15.82 % 0 % -9.75 % -
1 Year Return -39.15 % 1.46 % -14.22 % 0 % -10.32 % -
3 Year Return 0 % 0 % 0 % 0 % 0 % -
5 Year Return 0 % 0 % 0 % 0 % 0 % -
Dividends
AVGR ISRG BDX BDXA ALC MDLN
Dividend Yield Percentage (TTM) - - 1.99 % 1.84 % 0.42 % -
Dividend Paid and Capex Coverage Ration (TTM) -1804 % 5.61 % 1.75 % 1.74 % 3.02 % 6.53 %
Dividend Per Share (TTM) - - 4.17 % 3.28 % 0.33 % -
Payout Ratio (TTM) - - 71.28 % 67.9 % 15.49 % -
Profitability
AVGR ISRG BDX BDXA ALC MDLN
Gross Profit Margin TTM 26.18 % 66.06 % 45.44 % 45.76 % 55.12 % 24.48 %
Return on Assets TTM -133.04 % 13.84 % 3.03 % 3.2 % 3.32 % 1.78 %
Return on Equity TTM 1782.1 % 16.39 % 6.63 % 6.38 % 4.77 % 3.84 %
Return on Capital Employed TTM 300.81 % 15.81 % 5.48 % 5.06 % 5.06 % 3.51 %
Net Income Per EBT TTM 100 % 86.25 % 89.16 % 85.17 % 84.1 % 93.04 %
EBT Per Ebit TTM 110.13 % 112.42 % 73 % 75.87 % 86.34 % 58.52 %
EBIT Per Revenue TTM -217.39 % 29.27 % 11.8 % 12.4 % 14.16 % 8.59 %
Cash Flow To Debt Ratio TTM -93.74 % 1000.83 % 17.88 % 18.87 % 39.18 % 8.16 %
Receivables Turnover TTM 7.55 6.18 7.29 8.74 5.26 4.09
Payables Turnover TTM 7.27 13.39 - - 5.11 10.68
Inventory Turnover TTM 1.07 1.86 3.06 2.91 1.88 2.23
Fixed Asset Turnover TTM 481.56 % 188.39 % 312.12 % 314.44 % 198.09 % 298.53 %
Asset Turnover TTM 55.57 % 48.78 % 39.47 % 39.98 % 32.34 % 37.96 %
Operating Cash Flow Per Share TTM -18.36 8.54 11.97 11.91 4.16 1.73
Free Cash Flow Per Share TTM -18.37 7.02 9.32 9.23 3.11 1.46
Cash Per Share TTM 671.12 % 1672.27 % 299.71 % 263.44 % 303.41 % 121.33 %
Operating Cash Flow Sales Ratio TTM -188.6 % 30.11 % 15.71 % 15.48 % 20.13 % 9.7 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.06 % 82.19 % 77.84 % 77.52 % 74.75 % 84.68 %
Cash Flow Coverage Ratios TTM -93.74 % 1000.83 % 17.88 % 18.87 % 39.18 % 8.16 %
Price To Free Cash Flows Ratio TTM -0.1 68.24 22.45 24.48 25.61 31.46
Price To Operating Cash Flows Ratio TTM -0.03 56.05 17.55 14.93 19.09 25.85
Price Cash Flow Ratio TTM -0.03 56.05 17.55 14.93 19.09 25.85
Income Statement (TTM)
AVGR ISRG BDX BDXA ALC MDLN
Revenue $0.01B $10.06B $21.84B $21.84B $9.91B $25.51B
Gross Profit $0B $6.64B $9.92B $9.92B $5.51B $6.29B
Gross Profit Ratio 26.18% 66% 45.44% 45.44% 55.61% 24.66%
EBITDA $-0.02B $3.62B $4.96B $4.96B $2.68B $3.53B
Net Income $-0.02B $2.86B $1.68B $1.68B $1.02B $1.2B
EPS Diluted -23.31 7.87 5.83 5.83 2.05 1.52
Balance Sheet (MRQ)
AVGR ISRG BDX BDXA ALC MDLN
Long Term Debt $0B $0.26B $17.62B $17.62B $4.97B $16.75B
Total Liabilities $0.02B $2.69B $29.94B $29.94B $8.79B $19.45B
Total Equity $-0.01B $17.94B $25.39B $25.39B $21.55B $16.52B
Total Investments $0B $5.87B $0.01B $0.01B $0.91B $0.05B
Total Debt $0.02B $0.3B $19.18B $19.18B $5.14B $16.9B
Total Assets $0.01B $20.63B $55.33B $55.33B $30.35B $35.98B
Cash Flow Statement (TTM)
AVGR ISRG BDX BDXA ALC MDLN
Net Income $-0.02B $2.88B $1.68B $1.68B $1.02B $1.2B
Inventory $-0B $-1.06B $-0.41B $-0.41B $-0.05B $-0.55B
Dividends Paid $0B $0B $-1.2B $-1.2B $-0.13B $0B
Operating Cash Flow $-0.01B $3.03B $3.43B $3.43B $2.08B $1.77B
Capital Expenditure $-0B $-0.54B $-0.76B $-0.76B $-0.67B $-0.36B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 79.18
ANGO AngioDynamics, Inc. 10.98
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 142.56
ATRC AtriCure, Inc. 32.64
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVTR Avantor, Inc. 9.195
AZTA Azenta, Inc. 28.62
BAX Baxter International Inc. 19.79
BDX Becton, Dickinson and Company 175.92
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 17.03
BLFS BioLife Solutions, Inc. 22.25
COO The Cooper Companies, Inc. 83.04
DXR Daxor Corporation 12.45
EKSO Ekso Bionics Holdings, Inc. 9.9
FEMY Femasys Inc. 0.5196
ETFs With Exposure to AVGR
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 216.22
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 162.32
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 162.33
VEMPX Vanguard Extended Market Index InstlPlus 0 400.57
Unlock